“Venom: The Last Dance” had another weekend at the top of the box office. The Sony release starring Tom Hardy added $26.1 million to ticket sales, according to studio estimates Sunday.
It was a relatively quiet weekend for North American movie theaters as the presidential election approaches. The charts were dominated by major studio releases like “Venom 3,” “The Wild Robot” and “Smile 2,” while audiences roundly rejected the Tom Hanks, Robin Wright and Robert Zemeckis reunion “Here.” Thirty years after “Forrest Gump,” “Here” opened to just $5 million at 2,647 locations.
“Venom 3” only dropped 49% in its second weekend, which is a particularly low drop for a superhero movie, even though it didn’t really open as one no. more. In two weeks, the film grossed more than $90 million domestically; The first two opened to over $80 million. Globally, the picture is brighter given that it has already crossed the $300 million threshold.
Meanwhile, Universal and Illumination’s “The Wild Robot” continues to attract moviegoers even after six weeks (and when it’s available on video on demand), placing second with $7.6 million. This is an increase of 11% compared to last weekend. The animated charmer has earned over $121 million in North America and $269 million worldwide.
“’The Wild Robot’ has quietly been the absolute juggernaut of the fall season,” said Paul Dergarabedian, senior media analyst at Comscore. “For this film to see an increase after six weeks is astounding. »
“Smile 2” placed third with $6.8 million, helping to bring its worldwide total to $109.7 million.
The graphic novel “Here,” adapted by “Forrest Gump” screenwriter Eric Roth, was financed by Miramax and distributed by Sony’s TriStar. With a fixed-position camera, it takes the audience through the years in a single living room. Critics disagreed: Overall, it has a poor 36% on Rotten Tomatoes.
“It was a slow weekend anyway, but it didn’t have the resonance that many might have expected,” Dergarabedian said. “There are a lot of films aimed at the audience that ‘Here’ was looking for.”
Despite playing in nearly 1,000 additional venues, “Here” came in behind Focus Features’ papal thriller “Conclave,” which grossed $5.3 million. Showing in 1,796 theaters, “Conclave” was down just 20% from its debut last weekend and has grossed $15.2 million so far. Two Indian films also reached the top 10 on their debuts, “Bhool Bhulaiyaa 3” and “Singham Again”.
The overall box office continues to lag nearly 12% of 2023. But holiday films will likely give the industry a boost at the end of the year with titles like “Gladiator II” and “Wicked” on the way.
“In a few weeks, the situation will become much more competitive,” Dergarabedian said.
Jesse Eisenberg’s film “A Real Pain,” a comedy-drama about cousins on a Holocaust tour of Poland, opened in four theaters this weekend in New York and Los Angeles. It grossed approximately $240,000, or $60,000 per screen, which is among the three highest per-theater averages of the year. Searchlight Pictures will expand the highly acclaimed film nationally in the coming weeks, opening November 15 in more than 800 theaters.
However, box office charts don’t always give a complete picture of the cinematic landscape. This weekend, several relatively high-profile films showing in theaters failed to record total revenue for a variety of reasons, including the Clint Eastwood film “Juror #2,” the Steve McQueen World War II film “Blitz” and the darling of Cannes “Emilia Pérez”. Netflix, which runs “Emilia Pérez,” never releases box office reports. Apple Original Films is following suit with “Blitz,” a likely awards contender, which is in theaters before releasing on Apple TV+ on November 22.
“Juror No. 2” is a Warner Bros. release, and a well-reviewed one at that. The Eastwood-directed film stars Nicholas Hoult as a juror in a murder case facing a big moral dilemma. Domestic ticket sales have been suspended. The studio said it earned $5 million from international screenings, where it played on 1,348 screens.
Even major studios occasionally withhold box office numbers. Earlier this year, Disney failed to report on Daisy Ridley’s film “Lady and the Sea.” The results were notably retained during the COVID-19 pandemic.
“It’s really up to the distributors,” Dergarabedian said. “Often the reason certain films are not reported is because there is a risk that the quality of the film will be confused with the box office number.”
Final national figures will be released on Monday. According to Comscore, estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters were as follows:
1. “Venom: The Last Dance,” $26.1 million.
2. “The Wild Robot,” $7.6 million.
3. “Smile 2,” $6.8 million.
4. “Conclave,” $5.3 million.
5. “Here”, $5 million.
6. “We Live in Time,” $3.5 million.
7. “Terrify 3,” $3.4 million.
8. “Singham Again,” $2.1 million.
9. “Beetlejuice Beetlejuice,” $2.1 million.
10. “Bhool Bhulaiyaa 3,” $2.1 million.
This story has been corrected to reflect that the seventh film in the top 10 was “Terrifier 3,” not “Terrifier 2.”
Originally published:
